Advertisement

More articles from Research Watch

GPC2 May Be an Immunotherapeutic Target in High-Risk Neuroblastoma
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-180
Talimogene Laherparepvec Enhances the Efficacy of PD-1 Blockade
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-179
First-Line Dabrafenib plus Trametinib Has Activity in BRAF^V600E NSCLC
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-178
Gammaproteobacteria Metabolize Gemcitabine to Promote Chemoresistance
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-181
WNT and SHH Drive the Tumorigenesis of a Rare Embryonal Brain Tumor
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-177
ACTRT1 Inhibits Hedgehog Signaling to Suppress Basal Cell Carcinoma
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-173
Glioblastoma Stem Cell Clonal Dynamics Drive Intratumor Heterogeneity
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-172
Mitogen and Stress Signal Memory Regulates Daughter Cell Proliferation
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-176
Melanoma Risk Variants Prevent MC1R Palmitoylation and Activation
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-174
Targeting the c-Rel Subunit of NF-κB Inhibits Treg Function in Melanoma
Cancer Discovery Sep 2017, DOI: 10.1158/2159-8290.CD-RW2017-175